Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD. This evidence concerns the gene UGT1A1 and metabolic dysfunction-associated steatotic liver disease.